Who funds Alzheimer's disease drug development?

Alzheimer's & Dementia : Translational Research & Clinical Interventions
Jeffrey L CummingsGaram Lee

Abstract

Despite the increase in Alzheimer's disease (AD) cases in the United States, no new treatments have been approved in the United States since 2003. The costs associated with drug development programs are high and serve as a significant deterrent to AD therapeutic investigations. In this study, we analyze the sponsorship data for AD clinical trials conducted since 2016 to assess the fiscal support for AD clinical trials. We analyzed the funding sources of all AD trials over the past 5 years as reported on ClinicalTrials.gov. There were 136 trials being conducted for treatments in the US AD therapeutic pipeline on the index date of this study. Among non-prevention trials, disease-modifying therapies (DMT) in Phase 3 were almost entirely sponsored by the biopharmaceutical industry; Phase 2 DMT trials were split between the biopharmaceutical industry and funding from the National Institutes of Health (NIH) to academic medical centers (AMCs). The majority of prevention trials received sponsorship from public-private partnerships (PPP). Trials of symptomatic agents are equally likely to have biopharmaceutical or NIH/AMC sponsorship. Most trials with repurposed agents had NIH/AMC funding (89%). Since 2016, there has been consistent gro...Continue Reading

References

Oct 10, 2008·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Dean F WongGerhard Gründer
Dec 18, 2008·Orphanet Journal of Rare Diseases·Enrique Seoane-VazquezJay Visaria
Dec 25, 2010·Journal of Pharmacy & Bioallied Sciences·Aarti SharmaDushyant Kumar
Nov 21, 2012·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Barry D GreenbergEric R Siemers
Feb 2, 2013·Clinical and Translational Medicine·Michel GoldmanBarbara B Mittleman
Nov 29, 2013·Current Topics in Medicinal Chemistry·Lili M Portilla, Mark L Rohrbaugh
Mar 29, 2014·Annals of the New York Academy of Sciences·Troy J ScottTravis J Beaulieu
Jul 16, 2014·Alzheimer's Research & Therapy·Jeffrey L CummingsKate Zhong
Mar 12, 2015·The New England Journal of Medicine·Monique L AndersonRobert M Califf
Sep 1, 2013·Annals of Neurology·Joseph R BergerEva L Feldman
Dec 20, 2015·The Lancet. Psychiatry·Craig W RitchieUNKNOWN European Prevention of Alzheimer's Dementia (EPAD) Consortium
Sep 2, 2016·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Randall J BatemanUNKNOWN DIAN-TU Pharma Consortium for the Dominantly Inherited Alzheimer Network
Sep 21, 2016·Alzheimer's Research & Therapy·Jeffrey CummingsPhilip Scheltens
Sep 14, 2017·Alzheimer's Research & Therapy·Marta Crous-BouJosé Luis Molinuevo
Aug 17, 2016·Alzheimer's & Dementia : Translational Research & Clinical Interventions·Jeffrey CummingsGaram Lee
Oct 27, 2017·Alzheimer's & Dementia : Translational Research & Clinical Interventions·Jeffrey CummingsKate Zhong
Mar 23, 2018·Journal of Alzheimer's Disease : JAD·Lucilla Parnetti, Paolo Eusebi
Jun 30, 2018·Alzheimer's & Dementia : Translational Research & Clinical Interventions·Jeffrey CummingsKate Zhong
Sep 4, 2018·Alzheimer's & Dementia : Translational Research & Clinical Interventions·Jeffrey CummingsParvesh Kumar
Jul 7, 2019·Journal of Pharmacokinetics and Pharmacodynamics·Soumya Patel, Katherine I Miller Needleman
Jul 25, 2019·Alzheimer's & Dementia : Translational Research & Clinical Interventions·Jeffrey CummingsKate Zhong
May 15, 2020·Alzheimer's & Dementia : Translational Research & Clinical Interventions·Michael A Cole, Guy R Seabrook
Jul 23, 2020·Alzheimer's & Dementia : Translational Research & Clinical Interventions·Jeffrey CummingsKate Zhong
Aug 19, 2020·Alzheimer's Research & Therapy·Justin BauzonJeffrey Cummings
Mar 6, 2021·Lancet·Philip ScheltensWiesje M van der Flier

❮ Previous
Next ❯

Software Mentioned

MedAvante
BiOasis
QR
ADAMAS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Alzheimer's & Dementia : Translational Research & Clinical Interventions
Jeffrey L CummingsKate Zhong
Alzheimer's & Dementia : Translational Research & Clinical Interventions
Jeffrey L CummingsKazem Taghva
Alzheimer's & Dementia : Translational Research & Clinical Interventions
Jeffrey L CummingsKate Zhong
JAMA : the Journal of the American Medical Association
Zachary KassirWalid F Gellad
© 2021 Meta ULC. All rights reserved